Failure of cyclosporin A to induce transforming growth factor beta (TGF-β) synthesis in activated peripheral blood lymphocytes

Clinical Transplantation

Volumn 17, Issue 1, 2003, Pages 20-25

  Goppelt Struebe, Margarete ^a   Esslinger, Birgit ^a   Kunzendorf, Ulrich ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cyclooxygenase 2; Cyclosporine A; T lymphocytes; Transforming growth factor beta

Indexed keywords

CYCLOOXYGENASE 2; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PHYTOHEMAGGLUTININ; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BLOOD; BLOOD DONOR; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MEDIATOR; NEPHROTOXICITY; NORTHERN BLOTTING; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADULT; BLOTTING, NORTHERN; CYCLOSPORINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0038106034     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2003.02053.x     Document Type: Article

References (25)

1. DE VISSER KE, KAST WM. Effects of TGF-beta on the immune system: implications for cancer immunotherapy. Leukemia 1999: 13: 1188.
2. BITZER M, STERZEL RB, BÖTTINGER EP. Transforming growth factor-beta in renal disease. Kidney Blood Press Res 1998: 21: 1.
3. PIEK E, HELDIN C-H, TEN DIJKE P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999: 13: 2105.
4. BORDER WA, NOBLE NA. TGF - in kidney fibrosis: a target for gene therapy. Kidney Int 1997: 51: 1388.
5. ROBERTSON H, WONG WK, BURT AD, MOHAMED MA, TALBOT D, KIRBY JA. Relationship between TGF beta (1), intratubular CD103 positive T cells and acute renal allograft rejection. Transplant Proc 2001: 33: 1159.
6. PANKEWYCZ OG, MIAO L, ISAACS R et al. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Kidney Int 1996: 50: 1634.
7. SHARMA VK, BOLOGA RM, XU G-P et al. Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 1996: 49: 1297.
8. SHIHAB FS, TANNER AM, SHAO Y, WEFFER MI. Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int 1996: 50: 1904.
9. KEHRL JH, WAKEFIELD LM, ROBERTS AB et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986: 163: 1037.
10. LAI KN, HO RT, LEUNG JC, LAI FM, LI PK. Increased mRNA encoding for transforming factor-beta in CD4+ cells from patients with IgA nephropathy, Kidney Int 1994: 46: 862.
11. BENNETT WM. Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther 1996: 34: 515.
12. KHANNA AK, CAIRNS VR, BECKER CG, HOSENPUD JD. Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine. Transplantation 1999: 67: 882.
13. ISLAM M, BURKE JF Jr, MCGOWAN TA et al. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. Kidney Int 2001: 59: 498.
14. LI B, SEHAJPAL PK, KHANNA A et al. Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 1991: 174: 1259.
15. PRASHAR Y, KHANNA A, SEHAJPAL P, SHARMA VK, SUTHANTHIRAN M. Stimulation of transforming growth factor-beta 1 transcription by cyclosporine. FEBS Lett 1995: 358: 109.
16. AHUJA SS, SHRIVASTAN S, DANIELPOUR D, BALOW JE, BOUMPAS DT. Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes. Transplantation 1995: 60: 718.
17. HARTNER A, PAHL A, BRUNE K, GOPPELT-STRUEBE M. Regulation of cyclooxygenases and the PGE2 receptor in rat and human mesangioproliferative glomerulonephritis. Inflamm Res 2000: 49: 345.
18. MARTIN M, NEUMANN D, HOFF T, RESCH K, DEWITT DL, GOPPELT-STRUEBE M. Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int 1994: 45: 150.
19. STAHL RA, ADLER S, BAKER PJ et al. Cyclosporin A inhibits prostaglandin E2 formation by rat mesangial cells in culture. Kidney Int 1989: 35: 1161.
20. BATIUK TD, HALLORAN PF. Evidence that calcineurin is rate-limiting for primary human lymphocyte activation. J Clin Invest 1997: 100: 1894.
21. STROEBEL M, GOPPELT-STRUEBE M. Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells. J Biol Chem 1994: 269: 22952.
22. INIGUEZ MA, MARTINEZ-MARTINEZ S, PUNZON C, REDONDO JM, FRESNO M. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Biol Chem 2000: 275: 23627.
23. CRISTILLO AD, BIERER BE. Identification of novel targets of immunosuppressive agents by cDNA-based microarray analysis. J Biol Chem 2002: 277: 4465.
24. HOJO M, MORIMOTO T, MALUCCIO M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999: 397: 530.
25. WOLF G, THAISS F, STAHL RA. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects. Transplantation 1995: 60: 237.